AMANDA MAZZETTA: Open Payments
NPI 1801048103 · CLARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 57 payments from 13 companies in 2025. Trend: 2023 $830 · 2024 $1,130 · 2025 $1,086
Food & beverage: $1,005Education: $81
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $455 |
| Botanix SB Inc | 17 | $157 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| LEO Pharma Inc. | 3 | $70 |
| PFIZER INC. | 4 | $65 |
| Incyte Corporation | 3 | $49 |
| ABBVIE INC. | 2 | $33 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $23 |
| Almirall LLC | 1 | $19 |
Products named: DUPIXENT, SOFDRA, COSENTYX, ANZUPGO, LIBTAYO, BLU-U, OPZELURA, LITFULO.
Industry payments across NJ — which companies pay providers there.
